In this video, we take look on Biolidics launched rapid test kits for COVID-19 test in 10 minutes...
Not because I have symptoms, but because it was easy and accessible. This is how easy and fast it should be for everyone in the world. Hopefully tests like these will soon be available everywhere .
Coronavirus All About Playlist: https://www.youtube.com/playlist?list....
For Further more information about it GIVEN below:
Biolidics Singapore-listed medtech company Biolidics recently launched its rapid test kit for COVID-19 and has entered into a manufacturer agreement with a diagnostic kit manufacturer to customize and manufacture the rapid test kits. The first batch of Biolidics’ rapid test kits is expected to be available in April 2020. Biolidics has obtained provisional authorization from Singapore’s Health Science Authority (HSA) for its rapid test kit to be used in Singapore. The medtech company, which focuses on diagnostic cancer solutions, is working closely with Clear bridge Health to obtain the relevant approval and/or authorization from the various health authorities in the region for the use of the rapid test kit.
WHY IT MATTERS
Currently, polymerase chain reaction (“PCR”) testing is used to confirm patients with COVID-19 but it is a laboratory technique and requires laboratory specialists and dedicated medical testing equipment, hence PCR testing for COVID-19 generally requires at least 3 hours to obtain the test results. Using serum, plasma or whole blood samples, Biolidics’ rapid test kit can detect COVID-19 with an accuracy of more than 95% in ten minutes. The rapid test kit is easy to use and can enable more effective and efficient decentralized screening among suspected patients. For instance, it can be deployed for the screening of suspected patients in scenarios like border entry points or potential COVID-19 clusters. Biolidics have also emphasized that their COVID-19 rapid test kits have not been granted an Emergency Use Authorization by the FDA and that they are required to complete the listing of its COVID-19 rapid test kits before they can be distributed, marketed and sold to clinical laboratories and healthcare workers for point-of-care testing.
THE LARGER TREND
Late last month, Biolidics officially launched its COVID-19 rapid test kits and it has entered into a manufacturer agreement with a diagnostic kit manufacturer to customize and manufacture the rapid test kits, MobiHealthNews reported. The med tech company also recently obtained CE Marking for its COVID-19 rapid test kits, a notification process to the relevant authority which enables Biolidics to market and sell its rapid test kit in the European Union (EU). Their kit has also been approved for use by the FDA in the Philippines. In the US, Cellex became the first company to gain an FDA Emergency Use Authorization for a serology test. The test was designed to identify specific antibodies in the blood linked to coronavirus, which means it can be used to identify past coronavirus infections.
Currently, the authorization is limited to specific laboratories. The test is not meant to be used to determine whether a person is positive for the virus. The Biolidics test checks the blood for antibodies and can identify who was previously infected and may have already developed immunity to the virus. To date, 1.5 million people worldwide have been infected by COVID-19, and 88,000 have died from the epidemic.
In the meantime, Biolidics is working to gain approval to sell its infectious disease diagnostic kits in other countries in Asia, and with the U.S. Food and Drug Administration’s Emergency Use Authorization.
#coronavirustest, #rapidtest, #testkitforcovid-19, #covid-19rapidtestkit, #covid-19testkits, #rapidtestkit, #covid-19test, #covid-19rapidtest, #rapidtesting, #covid19, #antibodytest, #covid-19rapidtestingkits, #coronavirus, #coronavirustestkit, #latestreport, #rapiddiagnosticstest, #covid-19news, #teststandfortruth, #coronaviruslatest, #testing, #covid-19antibodytest, #coronaviruslatest news,coronavirus test kits,
Comments
Post a Comment